| PubMed: | Prediction of bioavailability of selected bisphosphonates using in silico methods towards categorization into a biopharmaceutical classification system. |
| PubMed: | [Establishment of zebrafish osteopenia model induced by dexamethasone]. |
| PubMed: | Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. |
| PubMed: | Bedside ultrasound in early diagnosis of neurogenic heterotopic ossification in patients with acquired brain injury. |
| PubMed: | WITHDRAWN: Pharmacological interventions for treating acute heterotopic ossification. |
| PubMed: | Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis. |
| PubMed: | Oroantral fistula from bisphosphonate induced osteonecrosis of the jaw. |
| PubMed: | Intracanal bisphosphonate does not inhibit replacement resorption associated with delayed replantation of monkey incisors. |
| PubMed: | Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials. |
| PubMed: | Application of UV-derivative spectrophotometry for determination of some bisphosphonates drugs in pharmaceutical formulations. |
| PubMed: | Etidronate: what is its place in treatment of primary osteoporosis and other demineralizing diseases today? |
| PubMed: | Direct stability-indicating method development and validation for analysis of etidronate disodium using a mixed-mode column and charged aerosol detector. |
| PubMed: | Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup. |
| PubMed: | Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. |
| PubMed: | The use of eidronate disodium in the prevention of heterotopic ossification in burn patients. |
| PubMed: | Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases. |
| PubMed: | Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. |
| PubMed: | Pseudogout attack induced during etidronate disodium therapy. |
| PubMed: | Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. |
| PubMed: | Ossification of the Achilles tendon--a case report. |
| PubMed: | Calcinosis universalis: a rare diagnosis. |
| PubMed: | [Heterotopic ossification in spinal cord injured patients]. |
| PubMed: | Effect of administration of retinol and etidronate on bone histomorphometric parameters in ovariectomized rats. |
| PubMed: | Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones? |
| PubMed: | Pharmacological interventions for treating acute heterotopic ossification. |
| PubMed: | Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup. |
| PubMed: | Spectrophotometric determination of some drugs for osteoporosis. |
| PubMed: | Chinese herbs and bone disease. |
| PubMed: | Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up. |
| PubMed: | Idiopathic calciphylaxis. |
| PubMed: | Conventional treatment of hypercalcemia of malignancy. |
| PubMed: | Advances in the biology and treatment of myeloma bone disease. |
| PubMed: | Familial fibrodysplasia ossificans progressiva: trial with etidronate disodium. |
| PubMed: | Paget's disease of the spine and its management. |
| PubMed: | Etidronic acid and steroid therapy: new indication. No proven impact on fractures. |
| PubMed: | Effect of intermittent cyclical treatment with etidronate disodium (HEBP) and calcium plus alphacalcidol in postmenopausal osteoporosis. |
| PubMed: | Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. |
| PubMed: | Risedronate: a clinical review. |
| PubMed: | Complexometric determination of diphosphonic acid derivatives. Part II. |
| PubMed: | Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. |
| PubMed: | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. |
| PubMed: | Etridronate therapy in the treatment and prevention of osteoporosis. |
| PubMed: | Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. |
| PubMed: | 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis. |
| PubMed: | A patient with Paget's disease of bone treated with etidronate disodium. |
| PubMed: | Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells. |
| PubMed: | Functional improvement in a patient with cerebral calcinosis using a bisphosphonate. |
| PubMed: | The use of cyclical etidronate in osteoporosis: changes after completion of 3 years treatment. |
| PubMed: | A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women. |
| PubMed: | Massive osteolytic bone metastases from a primary aortic sarcoma: a case report. |
| PubMed: | Myositis ossificans complicating severe Guillain-Barré syndrome. |
| PubMed: | Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. |
| PubMed: | Analysis of selected diphosphonic acid derivatives used in treatment of osteoporosis. Part I. Complexometric determination of diphosphonic acid derivatives. |
| PubMed: | Bisphosphonates for controlling pain from metastatic bone disease. |
| PubMed: | Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. |
| PubMed: | [Pseudosarcomatous osteolysis of the femur in a patient with Paget's bone disease treated with long-term etidronate disodium: apropos of a new case]. |
| PubMed: | New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis. |
| PubMed: | Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis. |
| PubMed: | Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty. |
| PubMed: | Direct stereological estimation of three-dimensional connectivity in rat vertebrae: effect of estrogen, etidronate and risedronate following ovariectomy. |
| PubMed: | Myositis ossificans progressiva: a 10-year follow-up on a patient treated with etidronate disodium. |
| PubMed: | Etretinate-induced heterotopic bone formation about the hip joint. A case report including ultrastructural study. |
| PubMed: | Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation. |
| PubMed: | Determination of bisphosphonate drugs in pharmaceutical dosage formulations by ion chromatography with indirect UV detection. |
| PubMed: | An experience of ischemic limb salvage associated with myositis ossificans of the left thigh. |
| PubMed: | Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy. |
| PubMed: | Hereditary hyperphosphatasia: 20 year follow-up and response to disodium etidronate. |
| PubMed: | Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis. |
| PubMed: | Antiresorptive drugs and trabecular bone turnover: validation and testing of a computer model. |
| PubMed: | Rachitic syndrome after disodium etidronate therapy in an adolescent. |
| PubMed: | Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. |
| PubMed: | Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification. |
| PubMed: | Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred. |
| PubMed: | The effects of etidronate disodium on progressive hearing loss from otosclerosis. |
| PubMed: | Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports. |
| PubMed: | Giant cell tumor arising in Paget's disease of bone. Recurrences after 36 years. |
| PubMed: | [Indications and limitations of non-hormonal treatments of osteoporosis]. |
| PubMed: | Determination of etidronate disodium tablets by ion chromatography with indirect UV detection. |
| PubMed: | [A one-year prospective study of disodium etidronate versus 17 beta estradiol in the prevention of postmenopausal osteoporosis]. |
| PubMed: | [A rare cause of hypercalcemia: familial hypocalciuric hypercalcemia]. |
| PubMed: | Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-induced osteopenia in growing rat femurs. |
| PubMed: | Didronel PMO. |
| PubMed: | [Osteoma cutis. Pathogenesis and therapeutic possibilities]. |
| PubMed: | Retention of etidronate in human, dog, and rat. |
| PubMed: | Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. |
| PubMed: | Warfarin in prevention of heterotopic ossification. |
| PubMed: | Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate). |
| PubMed: | Heterotopic bone formation in abdominal incisions. |
| PubMed: | Gallium nitrate. |
| PubMed: | Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. |
| PubMed: | Treatment of pulmonary alveolar microlithiasis with a diphosphonate--preliminary results of a case. |
| PubMed: | Calcinosis and metastatic calcification due to vitamin D intoxication. A case report and review. |
| PubMed: | Therapies for symptomatic primary osteoporosis. |
| PubMed: | Duration of etidronate effect demonstrated by serial bone scintigraphy. |
| PubMed: | Effect of daily etidronate on the osteolysis of multiple myeloma. |
| PubMed: | Pharmacologic elevation of blood inorganic phosphate in hypoxemic patients with COPD. |
| PubMed: | Etidronate for hypercalcemia of malignancy and osteoporosis. |
| PubMed: | Heterotopic ossification and peripheral nerve entrapment: early diagnosis and excision. |
| PubMed: | Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. |
| PubMed: | Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group. |
| PubMed: | Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC-3. |
| PubMed: | Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study. |
| PubMed: | Advances in the management of Paget's disease of bone. |
| PubMed: | Idiopathic infantile arterial calcification in two siblings: failure of treatment with diphosphonate. |
| PubMed: | Pseudoarthrosis in heterotopic ossification in spinal cord-injured patients. |
| PubMed: | [A new case of pseudosarcomatous osteolysis in a patient with Paget's disease treated with disodium etidronate]. |
| PubMed: | Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. |
| PubMed: | Pharmacologic management of Paget's disease. |
| PubMed: | Clinical and radiographic improvement of bone of the second lumbar vertebra in Paget's disease following therapy with etidronate disodium: a case report. |
| PubMed: | Vitamin D in Paget's disease of bone. |
| PubMed: | [Paget's disease: errors to be avoided]. |
| PubMed: | [Fibrodysplasia ossificans progressiva or Münchmeyer's disease]. |
| PubMed: | Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate. |
| PubMed: | [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate]. |
| PubMed: | Effect of etidronate disodium on bone turnover following surgical menopause. |
| PubMed: | Treatment of painful prostatic bone metastases with oral etidronate disodium. |
| PubMed: | Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice. |
| PubMed: | Stabilization of hearing loss in Paget's disease with calcitonin and etidronate. |
| PubMed: | False-negative bone imaging due to etidronate disodium therapy. |
| PubMed: | A clinical and biochemical assessment of etidronate disodium in patients with active rheumatoid arthritis. |
| PubMed: | [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation]. |
| PubMed: | [Failure of cimetidine and etidronate disodium to suppress parathyroid hormone level and hypercalcemia in primary hyperparathyroidism]. |
| PubMed: | Medical treatment of primary hyperparathyroidism: effects on parathormone and vitamin D metabolites. |
| PubMed: | Influence of disodium etidronate on Paget's disease of bone. |
| PubMed: | Synthetic human calcitonin in refractory Paget's disease of bone. |
| PubMed: | Heterotopic ossification and pseudoarthrosis in the shoulder following encephalitis. A case report and review of the literature. |
| PubMed: | Low back pain in Paget's disease of bone. |
| PubMed: | Therapy of hypercalcemia of malignancy. |
| PubMed: | Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. |
| PubMed: | Effects of intravenous etidronate disodium on skeletal and calcium metabolism. |
| PubMed: | Etidronate disodium in the management of malignancy-related hypercalcemia. |
| PubMed: | Effect of etidronate disodium on the interactions between malignancy and bone. |
| PubMed: | Etidronate disodium: a new therapy for hypercalcemia of malignancy. Proceedings of a symposium. |
| PubMed: | Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium. |
| PubMed: | The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study. |
| PubMed: | Effect of disodium etidronate (EHDP) on bone ingrowth in a porous material. |
| PubMed: | Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease. |
| PubMed: | A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium. |
| PubMed: | Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients. |
| PubMed: | Resection of heterotopic ossification and Didronel therapy--regaining wheelchair independence in the spinal cord injured patient. |
| PubMed: | Relief of metastatic bone pain with etidronate disodium. |
| PubMed: | Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled study. |
| PubMed: | Accelerated bone formation causing profound hypocalcemia in acute leukemia. |
| PubMed: | Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate. |
| PubMed: | [Congenital osteoma of the skin. Attempt at diphosphonate therapy]. |
| PubMed: | Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP). |
| PubMed: | A dynamic classification of Paget's disease. |
| PubMed: | Effective short term treatment of Paget's disease with oral etidronate. |
| PubMed: | Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone. |
| PubMed: | Advances in the treatment of metastatic prostatic cancer. |
| PubMed: | Paget's disease of bone. An update on management. |
| PubMed: | Progressive ossifying myositis in a cat. |
| PubMed: | Dose-dependent absorption of disodium etidronate. |
| PubMed: | Dose-dependent effect of calcium and magnesium etidronate on salicylic acid absorption in the rat. |
| PubMed: | [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)]. |
| PubMed: | [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats]. |
| PubMed: | [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease]. |
| PubMed: | Comparative study of etidronate and SR 41319, a new diphosphonate, on passive cutaneous anaphylaxis and phospholipase A2 activity. |
| PubMed: | [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia]. |
| PubMed: | Calcinosis universalis treated with disodium etidronate. |
| PubMed: | Intravenous etidronate in the management of malignant hypercalcemia. |
| PubMed: | Treatment of cancer-associated hypercalcemia with mithramycin and oral etidronate disodium. |
| PubMed: | Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy. |
| PubMed: | [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods]. |
| PubMed: | [Progressive myositis ossificans. Report of a case and results of treatment with disodium etidronate]. |
| PubMed: | Acute intravenous infusion of disodium dihydrogen (1-hydroxyethylidene)diphosphonate: mechanism of toxicity. |
| PubMed: | Effect of decreased O2 affinity of hemoglobin on work performance during exercise in healthy humans. |
| PubMed: | [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate]. |
| PubMed: | Immobilization hypercalcemia in acute spinal cord injury treated with etidronate. |
| PubMed: | Effects of disodium etidronate in murine tumor models. |
| PubMed: | Alternate calcitonin and etidronate disodium therapy for Paget's bone disease. |
| PubMed: | Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease. |
| PubMed: | Disodium etidronate in hypercalcaemia due to immobilisation. |
| PubMed: | Disodium etidronate (EHDP) |
| PubMed: | [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)]. |
| PubMed: | [Etidronic acid therapy in Paget's disease of bone]. |
| PubMed: | Heterotopic ossification heralded by a knee effusion. |
| PubMed: | Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. |
| PubMed: | Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. |
| PubMed: | Treatment of hyperparathyroidism with etidronate disodium. |
| PubMed: | Diphosphonates and painful feet. |
| PubMed: | Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). |
| PubMed: | Scalp vein sign in Paget's disease of bone. |
| PubMed: | Focal mineralization defect during disodium etidronate treatment of calcinosis. |
| PubMed: | Etidronate disodium in the treatment of Paget's disease of bone. |
| PubMed: | The effect of etidronate disodium (EHDP) on retinopathy in insulin-dependent diabetic patients. |
| PubMed: | [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate]. |
| PubMed: | Parenteral diphosphonates for treating malignant hypercalcemia. |
| PubMed: | Three adult cases resembling hereditary bone dysplasia. |
| PubMed: | Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. |
| PubMed: | [Treatment of hypercalcemia of tumoral origin with two diphosphonates]. |
| PubMed: | Treatment of hypercalcemia with etidronate disodium. |
| PubMed: | Effect of etidronate disodium on filterability of sickle cell erythrocytes. |
| PubMed: | Fibrodysplasia ossificans progressiva. A survey of forty-two cases. |
| PubMed: | Fibrodysplasia ossificans progressiva (myositis ossificans progressiva) treatment with disodium etidronate. |
| PubMed: | Paget's disease and the nervous system. |
| PubMed: | Etidronate disodium for Paget's disease. |
| PubMed: | Fibrodysplasia ossificans progressiva. Biochemical changes in blood serum, urine, skin, bone, and ectopic ossification. |
| PubMed: | Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate. |
| PubMed: | Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva. |
| PubMed: | Appearance of a gastric ulcer during diphosphonate therapy in a woman with CRST syndrome. |
| PubMed: | Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. |
| PubMed: | [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)]. |
| PubMed: | Etidronate disodium in postmenopausal osteoporosis. |
| PubMed: | In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid. |
| PubMed: | Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report). |
| PubMed: | Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets. |
| PubMed: | Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. |
| PubMed: | Radioimmunoassay of procollagen in serum of patients with Paget's disease of bone. |
| PubMed: | Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment. |
| PubMed: | [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans]. |
| PubMed: | Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man. |
| PubMed: | Disodium etidronate therapy for dystrophic cutaneous calcification. |
| PubMed: | [Study of the therapeutic effects of disodium etidronate (EHDP) on hypercholesteremia and on hypertriglyceridemia]. |
| PubMed: | Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. |
| PubMed: | [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans]. |
| PubMed: | Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). |
| PubMed: | Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. |
| PubMed: | Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique. |
| PubMed: | Preliminary safety assessment of disodium etidronate as an additive to experimental oral hygiene products. |
| PubMed: | Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey. |
| PubMed: | The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits. |